Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases
暂无分享,去创建一个
R. Vij | R. Hájek | H. Nahi | V. Milunović | J. Castillo | D. Vesole | A. Waszczuk-Gajda | D. Zawirska | M. Bittrich | K. M. Kortüm | M. Fiala | C. Chim | A. Jurczyszyn | P. Robak | E. Crusoé | D. Jayabalan | M. Raźny | J. Dávila | Jieqi Liu | Katarzyna Wiśniewska-Piąty
[1] H. Nahi,et al. Characteristics and outcomes of patients with multiple myeloma aged 21–40 years versus 41–60 years: a multi‐institutional case‐control study , 2016, British journal of haematology.
[2] S. Vincent Rajkumar,et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients , 2013, Leukemia.
[3] K. McGlynn,et al. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. , 2010, Blood.
[4] B. Barlogie,et al. Survival and years of life lost in different age cohorts of patients with multiple myeloma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] S. Trudel,et al. Age 40 years and under does not confer superior prognosis in patients with multiple myeloma undergoing upfront autologous stem cell transmplant. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] B. Barlogie,et al. Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy. , 2009, Blood.
[7] H. Kaufmann,et al. Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System , 2007, European journal of haematology.
[8] B. Barlogie,et al. International uniform response criteria for multiple myeloma , 2006, Leukemia.
[9] M. Höglund,et al. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation , 2002, European journal of haematology.
[10] R. Kyle,et al. Multiple myeloma in young patients: clinical presentation and treatment approach. , 1998, Leukemia & lymphoma.
[11] C. Klersy,et al. Multiple myeloma in younger patients: the role of age as prognostic factor , 1998, Annals of Hematology.
[12] R. Kyle,et al. Multiple myeloma in patients younger than 30 years. Report of 10 cases and review of the literature. , 1996, Archives of internal medicine.
[13] R. Kyle,et al. Presenting Features and Prognosis in 72 Patients With Multiple Myeloma Who Were Younger Than 40 Years , 1996, British journal of haematology.
[14] H. Lazarus,et al. Multiple myeloma in young men clinical course and electron microscopic studies of bone marrow plasma cells , 1980, Cancer.
[15] R. Alexanian,et al. Multiple myeloma in young persons. , 1976, Annals of internal medicine.
[16] Terry M Therneau,et al. Review of 1027 patients with newly diagnosed multiple myeloma. , 2003, Mayo Clinic proceedings.